All posts by: Michael Zand

About Michael Zand

Allogeneic CAR T-Cell Approaches for NHL – OncLive

Continue reading

2018-03-01 NEWS

Allogeneic CAR T-Cell Approaches for NHL
OncLive
And we’ve actually done quite a few patients where they’ve relapsed after allotransplant, and we then make cells from the patient, which are actually donor cells. But this group actually took T cells from the donor and were able to give it back and

and more »

Continue reading

2018-03-01 NEWS

As Cancer Immunotherapy Evolves, Challenges Compound for Diagnostic Development
360Dx
NEW YORK (GenomeWeb) – At various sessions during Cambridge Healthtech Institute’s Molecular Medicine Tri-Conference earlier this month, representatives from the diagnostics arena, pharmaceutical companies, and the medical oncology field discussed the

Continue reading

2018-03-01 NEWS

Science Daily

Stemcell study points to new approach to Alzheimer’s disease
Science Daily
The system that shuttles them around the cell is the endosomal network. For proteins to be properly processed, eliminated or recycled, this system must function correctly. In the new study reported this week, the UW Medicine-led research team used

and more »

Continue reading

2018-03-01 NEWS

Patch.com

Cancer Immunotherapy Topic of FREE Panel Discussion
Patch.com
Immunotherapy — harnessing the immune system to fight cancer — is positioned to revolutionize the way we treat cancer.Saturday’s free panel discussion will provide attendees an overview of this cutting-edge approach, and explain the latest